Covered recipient · General Payments record
RAZ WINIARSKY
Allopathic & Osteopathic Physicians Orthopaedic Surgery Orthopaedic Surgery of the Spine
General Payments · PY2018–2024
$70,234.32
- Reported across 97 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $68,400.00 | 13 |
| Food and Beverage | $101.18 | 5 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Royal Biologics | $68,400.00 | 13 |
| Valinor Pharma, LLC | $34.94 | 2 |
| VERTEX PHARMACEUTICALS INCORPORATED | $28.52 | 1 |
| FIDIA PHARMA USA INC. | $22.60 | 1 |
| Smith & Nephew, Inc. | $15.12 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Fidia Pharma USA Inc. | $22.60 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141159307 | CMS |
| Royal Biologics, Inc. | $1,200.00 | 02/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120089335 | CMS |
| Royal Biologics, Inc. | $1,200.00 | 02/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120089337 | CMS |
| Royal Biologics, Inc. | $6,000.00 | 02/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120089339 | CMS |
| Royal Biologics, Inc. | $6,000.00 | 03/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120089341 | CMS |
| Royal Biologics, Inc. | $6,000.00 | 04/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120089343 | CMS |
| Royal Biologics, Inc. | $6,000.00 | 05/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120089345 | CMS |
| Royal Biologics, Inc. | $6,000.00 | 06/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120089347 | CMS |
| Royal Biologics, Inc. | $6,000.00 | 07/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120089349 | CMS |
| Royal Biologics, Inc. | $6,000.00 | 08/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120089351 | CMS |
| Royal Biologics, Inc. | $6,000.00 | 09/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120089353 | CMS |
| Royal Biologics, Inc. | $6,000.00 | 10/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120089355 | CMS |
| Royal Biologics, Inc. | $6,000.00 | 11/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120089357 | CMS |
| Royal Biologics, Inc. | $6,000.00 | 12/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120089359 | CMS |
| Smith+Nephew, Inc. | $15.12 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149577186 | CMS |
| Valinor Pharma, LLC | $13.28 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130829365 | CMS |
| Valinor Pharma, LLC | $21.66 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130829367 | CMS |
| VERTEX PHARMACEUTICALS INCORPORATED | $28.52 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105915142 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.